Home > Insider Trading > Filing (0001181431-11-030231)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1385830	Neurogesx Inc	NGSX	Pharmaceutical Preparations (2834)	943307935

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1394522	K Jeffrey Tobias	C/O Neurogesx, Inc. 2215 Bridgepointe Parkway, Suite 200 San Mateo CA 94404	Evp Research & Dev & Cmo	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2011-05-12	600	$2.91	8,180	No	4	S	Direct
Common Stock	Disposition	2011-05-13	733	$2.81	7,447	No	4	S	Direct
Common Stock	Disposition	2011-05-16	1,333	$2.84	7,447	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Footnotes

Includes 782 shares acquired under the NeurogesX, Inc. 2007 Employee Stock Purchase Plan (the "Neurogesx ESPP") on May 17, 2010 and 1,333 shares acquired under the NeurogesX ESPP on November 15, 2010.
The sale price reported in column 4 of Table I represents the weighted average sale price of the shares sold ranging from $2.80 to $2.81 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4.
The sale price reported in column 4 of Table I represents the weighted average sale price of the shares sold ranging from $2.82 to $2.85 per share.
Includes 1,333 shares acquired under the NeurogesX ESPP on May 16, 2011.